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Abstract
The ferric nitrilotriacetate-induced carcinogenesis model is unique in that reactive oxygen
species-free radicals are involved in the carcinogenic process. But the effects of iron-withdrawal
in the progression of renal cell carcinoma are not well understood. We performed repeated phle-
botomies on animals that had been administered ferric nitrilotriacetate in the initiation stage of
renal cell carcinoma (phlebotomy group), and compared the development of renal tumors with
those not receiving repeated phlebotomies (non-phlebotomy group). Ferric nitrilotriacetate-treated
male Wistar rats were randomly divided into 2 groups: a phlebotomy group (21 rats) and a non-
phlebotomy group (17 rats). Ten age-adjusted normal rats were also observed as a normal group.
Hematocrit was maintained under 25% in the phlebotomy group. Hematocrit levels in the normal
group and in the non-phlebotomy group were not significantly different. As a result, the incidence
of renal cell carcinoma was not significantly different between phlebotomy and non-phlebotomy
animals. However, the total weight of the renal cell carcinoma was significantly heavier in the
animals from non-phlebotomy group than in those from the phlebotomy group (23.64 g +/- 18.54
vs. 54.40 g +/- 42.40, P< 0.05). The present study demonstrated that phlebotomy after the admin-
istration of ferric nitrilotriacetate did not reduce the incidence of renal cell carcinoma. In addition,
we showed that iron withdrawal at the promotion stage of carcinogenesis will retard tumor growth.
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Normal 136.50±66.03 634.83±65.11 36.76±3.75
Phlebotomy 22.67± 2.89??896.67±82.70?20.33±2.60?
















Normal 10 10 0(0)
Phlebotomy 21 17 9(53) 23.64±18.54?
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